Tumor necrosis factor-alpha and polycystic ovarian syndrome: A clinical, biochemical, and molecular genetic study

Genetic Testing and Molecular Biomarkers

Volumn 18, Issue 9, 2014, Pages 605-609

  Thathapudi, Sujatha ^a   Kodati, Vijayalakshmi ^a   Erukkambattu, Jayashankar ^b   Katragadda, Anuradha ^c   Addepally, Uma ^d   Hasan, Qurratulain ^a,b  

^a Vasavi Medical and Research Centre   (India)

^b Kamineni Academy of Medical Sciences and Research Centre   (India)

^c Department of Gynaecology Anu's Fertility Centre   (India)

^d JAWAHARLAL NEHRU TECHNOLOGICAL UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

TNF PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; BLOOD; CLINICAL TRIAL; FEMALE; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; OVARY POLYCYSTIC DISEASE; PATHOLOGY; PROMOTER REGION;

ADOLESCENT; ADULT; FEMALE; GENOTYPE; HUMANS; POLYCYSTIC OVARY SYNDROME; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84906912253     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2014.0151     Document Type: Article

References (20)

1. Azziz R, Carmina E, Dewailly D, et al. (2006) Position statement: Criteria for Defining PCOS as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline. J Clin Endocrinol Metab 91:4237-4245.
2. Azziz R, Carmina E, Dewailly D, et al. (2009) The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: The complete task force report. Fertil Steril 91: 456-488.
3. Azziz R, Sanchez LA, Knochenhauer ES, et al. (2004) Androgen excess in women: Experience with over 1000 consecutive patients. J Clin Endocrinol Metab 89:453-462.
4. Chae SJ, Kim JJ, Choi YM, et al. (2008) Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women. Hum Reprod 23:1924-1931.
5. Chen X, Ni R, Mo Y, et al. (2010) Appropriate BMI levels for PCOS patients in Southern China. Hum Reprod 25:295-302.
6. Dasgupta S, Mohan Reddy B (2008) Present status of understanding on the genetic etiology of polycystic ovary syndrome. J Postgrad Med 54:115-120.
7. Dunaif A (1997) Insulin resistance and the polycystic ovary syndrome: Mechanism and implication for pathogenesis. Endocr Rev 18:774-780.
8. Escobar-Morreale HF, Calvo RM, Sancho J, SanMilan JL (2001) TNF-a and hyperandrogenism: A clinical and biochemical, and molecular genetic study. J Clin Endocrinol Metab 86: 3761-3767.
9. Govindan S, Ahamad SN, Vedicherla B, et al. (2007) Association of progesterone receptor gene polymorphism (PROGINS) with endometriosis, uterine fibroids and breast cancer. Cancer Biomark 3:73-78.
10. Hart R, Hickey M, Franks S (2004) Definition, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome. Best Prac Res Obstet Gynecol 18:671-683.
11. Hotamisligil GS (1999) The role of TNF-a and TNF receptor in obesity and insulin resistance. J Intern Med 245:621-625.
12. Korhonen S, Romppanen EL, Hiltunen M, et al. (2002) Lack of association between-C850T polymorphism of the gene encoding tumor necrosis factor-alpha and polycystic ovary syndrome. Gynecol Endocrinol 16:271-274.
13. Legro RS (1995) The genetics of polycystic ovary syndrome. Am J Med 98 Suppl 1A:165.
14. Milner CR, Craig JE, Hussey ND, Norman RJ (1999) No association between the-308 polymorphism in the tumor necrosis factor alpha promoter region and polycystic ovaries. Mol Hum Reprod 5:5-9.
15. Movva S, Alluri R, Komandur S, et al. (2007) Relationship of angiotensin-converting gene polymorphism with nephropathy associated with type 2 diabetes mellitus in Asian Indians. J Diabetes Complications 21:237-241.
16. Pazarbasi A, Kasap M, Guzel AI, et al. (2007) Polymorphisms in the tumor necrosis factor alpha gene in Turkish women with pre-eclampsia and eclampsia. Acta Med Okayama 61: 153-160.
17. Rodriguez S, Gaunt TR, Day IN (2009) Hardy-Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies. Am J Epidemiol 169:505-514.
18. Urbanek M, Lergo RS, Driscoll DA, et al. (1999) Thirty-seven candidate genes for polycystic ovary syndrome: Strongest evidence for linkage is with follistatin. Proc Natl Acad Sci USA 96:8573-8578.
19. Wijeyratne CN, Balen AH, Barth JH, Belchetz PE (2002) Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: Is there a difference? Clin Endocrinol(Oxf) 57:343-350.
20. Yun JH, Choi JW, Lee KJ, et al. (2011) The Promoter-1031 (T/C) polymorphism in tumor necrosis factor-alpha associated with polycystic ovary syndrome. Reprod Biol Endocrinol 9:131.